ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 07:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 02:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...
Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight
January 09, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Nanomedicine Global Market to Observe Stupendous Growth at a CAGR of ~11% by 2028 | DelveInsight Nanomedicine is experiencing heightened demand,...
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
November 13, 2023 02:00 ET
|
ViaNautis Bio
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines ViaNautis’s proprietary drug delivery platform polyNaut® is designed to deliver...
Global Nanomedicine Market Size To Grow USD 564.15 Billion by 2032 | CAGR of 12.4%
September 18, 2023 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Global Nanomedicine Market Size is To Grow from USD 174.13 Billion in 2022 to USD 564.15 Billion by 2032, at a Compound Annual Growth...
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on New ‘Dendranib’ Nanomedicine Candidate at the 16th International Society of Neuroimmunology Congress (ISNI)
August 15, 2023 08:30 ET
|
Ashvattha Therapeutics
Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, in a mouse model of multiple sclerosis REDWOOD CITY, Calif.,...
Nanomedicine Market to Reach USD 512.5 Bn by 2028, growing at a CAGR of 12.6% - Global Analysis by TMR
May 10, 2023 15:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global nanomedicine industry was valued at USD 198.9 Bn in 2020 and to reach USD 512.5 Bn by 2028 with a CAGR of 12.6% from...
LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles
January 03, 2023 09:00 ET
|
leon-nanodrugs GmbH
LEON achieved superior accuracy in development of its proprietary reactor, facilitating exceptional inter-device reproducibility of particle size and distribution, and thus seamless process transfer,...
Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing
October 26, 2022 05:00 ET
|
Leon-nanodrugs GmbH
LEON and Harro Höfliger to build and commercialize LEON’s NANOus, a novel aseptic manufacturing device to facilitate commercial production of LNP-encapsulated genetic materials and other APIsBy...
Global Biopharmaceutical and Biomedicine Market to Surpass US$ 1,165,862.8 Million by 2030, Says Coherent Market Insights (CMI)
July 05, 2022 08:40 ET
|
CMI
Seattle, July 05, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global biopharmaceutical and biomedicine market is estimated to be valued at US$ 561,375.9 million in 2022 and...